These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 32716214)

  • 21. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
    Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y
    Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.
    Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J
    Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of methylation-driven genes related to prognosis in clear-cell renal cell carcinoma.
    Wang J; Zhang Q; Zhu Q; Liu C; Nan X; Wang F; Fang L; Liu J; Xie C; Fu S; Song B
    J Cell Physiol; 2020 Feb; 235(2):1296-1308. PubMed ID: 31273792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of cyclin F/CCNF as an independent prognostic factor for poor survival in clear cell renal cell carcinoma.
    Kwiatkowski M; Krajewski A; Durślewicz J; Buchholz K; Grzanka D; Gagat M; Zabrzyński J; Klimaszewska-Wiśniewska A
    Sci Rep; 2024 Apr; 14(1):9280. PubMed ID: 38654021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.
    Liu J; Liu Z; Liu Q; Li L; Fan X; Wen T; An G
    Oncol Rep; 2018 Oct; 40(4):2023-2035. PubMed ID: 30066941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
    He Z; Deng T; Duan X; Zeng G
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32789468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
    Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
    Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
    Shi S; Ye S; Wu X; Xu M; Zhuo R; Liao Q; Xi Y
    Yonsei Med J; 2019 Nov; 60(11):1013-1020. PubMed ID: 31637882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel PANoptosis-related gene signature for predicting the prognosis in clear cell renal cell carcinoma.
    Yue D; Ren C; Li H; Liu X
    Medicine (Baltimore); 2024 Sep; 103(39):e39874. PubMed ID: 39331898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and Validation of Tumor Microenvironment-Associated Signature in Clear-Cell Renal Cell Carcinoma through Integration of DNA Methylation and Gene Expression.
    Ye Z; Xu J; Zhang X; Zhang Y; Ivanova D; Lu W; Zhang J; Li F; Chen X; Wang Y; Wang M; Xie B
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
    Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
    Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
    Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
    Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and prognostic value of ABC transporter family member ABCG1 gene in clear cell renal cell carcinoma.
    Meng F; Xiao Y; Xie L; Liu Q; Qian K
    Channels (Austin); 2021 Dec; 15(1):375-385. PubMed ID: 33825659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ID1 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Deterioration of Clear Cell Renal Cell Carcinoma.
    Qiu X; Gu Y; Ni Y; Li Q
    Biomed Res Int; 2020; 2020():2064582. PubMed ID: 33178820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptome analysis revealed a novel nine-gene prognostic risk score of clear cell renal cell carcinoma.
    Al Sharie AH; Al Masoud EB; Jadallah RK; Alzghoul SM; Darweesh RF; Al-Bataineh R; Lataifeh LN; Salameh ST; Daoud MN; Rawashdeh TH; El-Elimat T; Alali FQ
    Medicine (Baltimore); 2024 Sep; 103(39):e39678. PubMed ID: 39331921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Expression and Prognostic Value of Co-stimulatory Molecules in Clear Cell Renal Cell Carcinoma (CcRcc).
    Wu C; Cai X; He C
    Comb Chem High Throughput Screen; 2024; 27(2):335-345. PubMed ID: 37171001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive analysis of MAPK genes in the prognosis, immune characteristics, and drug treatment of renal clear cell carcinoma using bioinformatic analysis and Mendelian randomization.
    Zheng X; Wang Y; Qiu X
    Eur J Pharmacol; 2024 Oct; 980():176840. PubMed ID: 39038636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.
    He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers.
    Joosten SC; Odeh SNO; Koch A; Buekers N; Aarts MJB; Baldewijns MMLL; Van Neste L; van Kuijk S; Schouten LJ; van den Brandt PA; Tjan-Heijnen VC; van Engeland M; Smits KM
    Clin Epigenetics; 2021 May; 13(1):103. PubMed ID: 33947447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of PI3K-AKT Pathway-Related Genes and Construction of Prognostic Prediction Model for ccRCC.
    Hu S; Zhang X; Xin H; Guo M; Xiao Y; Chang Z; Luo Q; Li Y; Zhu C
    Cancer Rep (Hoboken); 2024 Sep; 7(9):e70010. PubMed ID: 39233640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.